Correlation Between Pharmagreen Biotech and Khiron Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmagreen Biotech and Khiron Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmagreen Biotech and Khiron Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmagreen Biotech and Khiron Life Sciences, you can compare the effects of market volatilities on Pharmagreen Biotech and Khiron Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmagreen Biotech with a short position of Khiron Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmagreen Biotech and Khiron Life.

Diversification Opportunities for Pharmagreen Biotech and Khiron Life

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharmagreen and Khiron is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Pharmagreen Biotech and Khiron Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Khiron Life Sciences and Pharmagreen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmagreen Biotech are associated (or correlated) with Khiron Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Khiron Life Sciences has no effect on the direction of Pharmagreen Biotech i.e., Pharmagreen Biotech and Khiron Life go up and down completely randomly.

Pair Corralation between Pharmagreen Biotech and Khiron Life

Given the investment horizon of 90 days Pharmagreen Biotech is expected to generate 15.56 times less return on investment than Khiron Life. But when comparing it to its historical volatility, Pharmagreen Biotech is 12.83 times less risky than Khiron Life. It trades about 0.13 of its potential returns per unit of risk. Khiron Life Sciences is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Khiron Life Sciences on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Khiron Life Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharmagreen Biotech  vs.  Khiron Life Sciences

 Performance 
       Timeline  
Pharmagreen Biotech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmagreen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, Pharmagreen Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Khiron Life Sciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Khiron Life Sciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Khiron Life reported solid returns over the last few months and may actually be approaching a breakup point.

Pharmagreen Biotech and Khiron Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmagreen Biotech and Khiron Life

The main advantage of trading using opposite Pharmagreen Biotech and Khiron Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmagreen Biotech position performs unexpectedly, Khiron Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Khiron Life will offset losses from the drop in Khiron Life's long position.
The idea behind Pharmagreen Biotech and Khiron Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance